[A case of RAEB-t treated by G-CSF showing complete remission after MST-16 treatment for subsequent reversible leukemia].

Abstract

A seventy-five-year-old female with general fatigue, high fever and anemia was admitted. Her chest X-ray film revealed pneumonia. She was diagnosed as RAEB-t with the normal karyotype by peripheral blood film and bone marrow aspiration; 125 micrograms/ml of G-CSF was administered s.c. daily in order to increase neutrophil count because of the prolongation of pneumonia. Her blast cells in both peripheral blood and bone marrow showed a remarkable increase by G-CSF. After the cessation of G-CSF administration, blast cells decreased rapidly, and neutrophil count in the peripheral blood increased. Her pneumonia was then cured. After 5 months of stable hematological state, 60% of her bone marrow cells became occupied by blast cells again. So 2 consecutive courses of 14 days p.o. administration of 1,200 mg MST-16/day were tried. Three months after the first MST-16 trial, her bone marrow showed complete remission (CR) which lasted about 4 months. But she died of sepsis after the first relapse. Her bone marrow in CR still revealed several features of dyspoiesis.

• Authors: T Murate, H Ohashi, Y Kagami, T Hotta, T Murase, Y Hirota, K Kimura
• Journal: Gan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 18 Issue 12 Pg. 2155-8 (Sep 1991) ISSN: 0385-0684 [Print] Japan
• PMID: 1716093 (Publication Type: Case Reports, English Abstract, Journal Article)

Chemical References

• Antineoplastic Agents
• Piperazines
• Granulocyte Colony-Stimulating Factor
• sobuzoxane

Topics

• Acute Disease
• Administration, Oral
• Aged
• Anemia, Refractory, with Excess of Blasts (pathology, therapy)
• Antineoplastic Agents (administration & dosage, therapeutic use)
• Bone Marrow (pathology)
• Clone Cells
• Female
• Granulocyte Colony-Stimulating Factor (administration & dosage, therapeutic use)
• Humans
• Leukemia (drug therapy, pathology)
• Leukocyte Count
• Neutrophils
• Piperazines (administration & dosage, therapeutic use)
• Remission Induction